- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:02 | Bullion Gold Resources Corp.: Bullion Announces $1.5 Million Private Placement | 195 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 2, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce a private placement of up to 16,666,667 units of... ► Artikel lesen | |
| Mi | Bullion Gold Resources Corp (2): Bullion Gold optionee to resume drilling at Bousquest | 4 | Stockwatch | ||
| Mi | Bullion Gold Resources Corp.: Olympio to Resume Drilling at Bousquet Gold Project, Earns 51% interest | 424 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 27, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce that optionee Olympio Metals Limited (ASX: OLY) ("Olympio")... ► Artikel lesen | |
| 19.05. | Bullion Gold Resources Corp (2): Bullion Gold appoints Britt as technical committee | 2 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 13.05. | Bullion Gold Resources Corp (2): Bullion Gold completes Terragold 3-D geological model | 3 | Stockwatch | ||
| 13.05. | Bullion Gold Resources Corp.: BULLION Completes Terragold Historical Compilation and Uploads Leapfrog 3D Geological Model on YouTube | 272 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 13, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce the completion of a comprehensive compilation and... ► Artikel lesen | |
| 05.05. | Bullion Gold Resources Corp.: BULLION GOLD Confirms the Lateral Continuity of the LANGLADE Showing, Intersecting 41.0 m Grading 1.03% CuEq and 30.2 m Grading 0.95% CuEq | 320 | Newsfile | Montreal, Quebec--(Newsfile Corp. - May 5, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased to announce assay results from the first two diamond drill holes... ► Artikel lesen | |
| 14.04. | Bullion Gold Resources Corp (2): Bullion Gold appoints Britt as president, CEO | 1 | Stockwatch | ||
| 13.04. | Bullion Gold Resources Corporation: Bullion Gold Announces the Appointment of Simon Britt as President and Chief Executive Officer | 403 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 13, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("the Company" or "Bullion") is pleased to announce the appointment of Mr. Simon Britt as President... ► Artikel lesen | |
| 10.04. | Bullion Gold Resources Corp (2): Bullion Gold completes diamond drilling at Langlade | 3 | Stockwatch | ||
| 09.04. | Bullion Gold Resources Corporation: Bullion Gold Completes Drilling Program on Langlade Project | 309 | Newsfile | Montreal, Quebec--(Newsfile Corp. - April 9, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it has successfully completed its diamond... ► Artikel lesen | |
| 31.03. | Bullion Gold Resources Corporation: 19.40m @ 17.29 g/t Au in Hole BO-26-63 at Bousquet | 424 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 31, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") and its partner Olympio Metals are pleased to announce the final... ► Artikel lesen | |
| 24.03. | Bullion Gold Resources Corp (2): Bullion Gold drills 7.5 m of 41.81 g/t Au at Bousquet | 2 | Stockwatch | ||
| 23.03. | Bullion Gold Resources Corporation: Bonanza Gold Intercept from Phase 2 Drilling at Bousquet | 538 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 23, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce first assay results from the Phase 2 drilling... ► Artikel lesen | |
| 05.03. | Bullion Gold Resources Corp (2): Bullion Gold plans 25,000 m drill program at Terragold | 3 | Stockwatch | ||
| 05.03. | Bullion Gold Resources Corporation: Bullion Gold Plans a 25,000 M Drilling Program on Its Terragold Project | 473 | Newsfile | Montreal, Quebec--(Newsfile Corp. - March 5, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is currently preparing an application for a forestry intervention... ► Artikel lesen | |
| 26.02. | Bullion Gold Resources Corporation: Bullion Gold Obtains Drilling Permits for the Langlade Project | 433 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has received approval from the Quebec Ministry... ► Artikel lesen | |
| 17.02. | Bullion Gold Resources Corporation: Diamond Drilling Intersects Multiple Visible Gold Occurrences at the Bousquet Gold Project | 597 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 17, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and it's partner Olympio Metals are pleased to announce that the... ► Artikel lesen | |
| 13.02. | Bullion Gold Resources Corp (2): Bullion Gold restarts drilling at Bousquet project | 1 | Stockwatch | ||
| 12.02. | Bullion Gold Resources Corporation: Drilling Resumes at Bousquet Gold Project, Quebec | 360 | Newsfile | Montréal, Québec--(Newsfile Corp. - February 12, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it's partner Olympio Metals ("Olympio")... ► Artikel lesen |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TYRA BIOSCIENCES | 30,390 | 0,00 % | Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | - Launched "dabogratinib 3x3" strategy to pursue 3 late-stage clinical studies in LG-UTUC, IR NMIBC and ACH, 3 potential blockbuster indications -
- Interim Ph2... ► Artikel lesen | |
| CG ONCOLOGY | 59,25 | +0,03 % | CG Oncology, Inc. - 8-K, Current Report | ||
| ARRIVENT BIOPHARMA | 30,690 | +0,03 % | Cantor Fitzgerald reiterates Overweight on ArriVent BioPharma stock | ||
| QIAGEN | 30,900 | +0,28 % | DEUTSCHE BANK RESEARCH stuft QIAGEN NV auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Qiagen mit einem Kursziel von 43 US-Dollar auf "Buy" belassen. Das Interesse der Investoren habe vor allem dem Tuberkulosetest... ► Artikel lesen | |
| RELAY THERAPEUTICS | 16,600 | +16,41 % | H.C. Wainwright raises Relay Therapeutics stock price target to $28 on trial data | ||
| VERADERMICS | 101,64 | 0,00 % | Veradermics to present hair loss drug trial data on Friday | ||
| MODERNA | 39,675 | +0,18 % | Moderna, Inc.: Moderna to Present at Upcoming Conference in June 2026 | CAMBRIDGE, MA / ACCESS Newswire / June 2, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference:Goldman Sachs 47th Annual Global Healthcare... ► Artikel lesen | |
| KAILERA THERAPEUTICS | 23,180 | 0,00 % | Kailera Therapeutics, Inc.: Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates | Important progress across four clinical-stage programs demonstrating depth and breadth of obesity pipeline Initiated five late-stage global clinical trials in obesity, including the ribupatide injection... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 310,00 | -7,51 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Vormatrigine Program Update | POWER1 Study in highly refractory patients with focal onset seizures did not meet its primary success measure Secondary measure, the 50% response rate, was met and seizure reduction during the second... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 15,130 | -3,69 % | Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical Developments | ||
| BIONTECH | 77,05 | -2,78 % | Vorsicht bei BioNTech! Novo Nordisk gibt Gas! Kaufchance bei Vidac Pharma Aktie! | Kaufstimmung bei Novo Nordisk. Die Aktie des dänischen Pharmagiganten scheint den seit Sommer 2024 begonnenen Abwärtstrend zu verlassen. Anleger reagieren auf positive Meldungen. Bei Vidac Pharma ist... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,695 | -2,51 % | Recursion Pharmaceuticals: Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | ||
| REVOLUTION MEDICINES | 140,35 | -0,36 % | Revolution Medicines - RVMD: potenzieller Durchbruch bei Bauchspeicheldrüsenkrebs treibt den Aktienkurs! | Starke Phase-3-Daten! Längere Überlebenszeit. Revolution Medicines (RVMD) rückt mit Daraxonrasib näher an einen möglichen Milliardenmarkt in der Krebsmedizin heran. Revolution Medicines (RVMD) - US76155X1000... ► Artikel lesen | |
| EDGEWISE THERAPEUTICS | 39,300 | -2,38 % | Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business | Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs.Transaction includes sevasemten, a late-stage investigational treatment for... ► Artikel lesen | |
| AVALYN PHARMA | 26,660 | 0,00 % | This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday |
Das Unternehmen BULLION GOLD RESOURCES CORPORATION kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,047 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.